We evaluated the relationships between miR-29c-3p, miR-4492, PTX3, RPL22, CABIN1, RELA, SPARCL1, and TMOD1 levels and the clinicopathological features of meningioma patients including sex, age, tumor grade, tumor volume, calcification, progesterone receptor status, and p53 and Ki67 levels, as well as the correlation between the level of miRNAs and their targets. Here, SPARCL1 is linked to meningioma.